Weikang Bio-Technology announces conference call to discuss second quarter fiscal 2010 results
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine, Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that it will conduct a conference call at 9:00 am Eastern Time on Tuesday, August 17, 2010 to discuss the second quarter fiscal 2010 results.
MISSISSAUGA, ON, Nov. 11, 2011 /CNW/ - YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer-related products, today reported operational and financial results for its first quarter of fiscal 2012, ended September 30, 2011.